A carregar...

TLR9 signaling mediates adaptive immunity following systemic AAV gene therapy

An ongoing concern of in vivo gene therapy is adaptive immune responses against the protein product of a transgene, particularly for recessive diseases in which antigens are not presented to lymphocytes during central tolerance induction. Here we show that Toll-like receptor 9 (TLR9) signaling activ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Immunol
Main Authors: Ashley, Scott N., Somanathan, Suryanarayan, Giles, April R., Wilson, James M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6903695/
https://ncbi.nlm.nih.gov/pubmed/31703913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2019.103997
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!